Skip to main content

Advertisement

Log in

Glucagon Is a Safe and Inexpensive Initial Strategy in Esophageal Food Bolus Impaction

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Controversy exists about the utility of pharmacologic agents and endoscopic technique used for esophageal food bolus impaction.

Aim

To evaluate the utility of glucagon and the technique used for endoscopic removal, including the rate of success and the adverse events of the techniques.

Methods

The database of the largest healthcare provider in southeastern Wisconsin was retrospectively reviewed for patients presenting with esophageal food bolus impaction. Data extracted included glucagon administration and its success rate, outcome of radiographic studies, and the endoscopic method of removal and adverse events associated with it, including 30-day mortality.

Results

A total of 750 patients were identified with food bolus impaction from 2007 to 2012. Glucagon was administered in 440 patients and was successful in 174 (39.5 %). Endoscopic removal was performed in 470 patients and was successful in 469 (99.8 %). The push technique was utilized in 209 patients, reduction in the bolus size by piecemeal removal followed by the push technique was utilized in 97 patients, and the pull technique was utilized in 107 patients. There were no perforations with endoscopic removal. Only 4.5 % of the X-rays performed reported a possible foreign body within the esophagus. Glucagon was a significantly less-expensive strategy than endoscopic therapy (p < 0.0001).

Conclusion

Glucagon is low cost, is moderately effective, and may be considered as an initial strategy. Endoscopic removal regardless of technique is safe and effective. The yield of radiography is poor in the setting of food bolus impaction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Colon V, Grade A, Pulliam G, et al. Effect of doses of glucagon used to treat food impaction on esophageal motor function of normal subjects. Dysphagia. 1999;14:27–30.

    Article  CAS  PubMed  Google Scholar 

  2. Tibbling L, Bjorkhole A, Jansson E, et al. Effect of spasmolytic drugs on esophageal foreign bodies. Dysphagia. 1995;10:126–127.

    Article  CAS  PubMed  Google Scholar 

  3. Sodeman TC, Harewood GC, Baron TH. Assessment of the predictors of response to glucagon in the setting of acute esophageal food bolus impaction. Dysphagia. 2004;19:18–21.

    Article  PubMed  Google Scholar 

  4. Arora S, Galich P. Myth: glucagon is an effective first-line therapy for esophageal foreign body impaction. CJEM. 2009;11:169–171.

    PubMed  Google Scholar 

  5. Thimmapuram J, Oosterveen S, Grim R. Use of glucagon in relieving esophageal food bolus impaction in the era of eosinophilic esophageal infiltration. Dysphagia. 2013;28:212–216.

    Article  PubMed  Google Scholar 

  6. Robbins MI, Shortsleeve MJ. Treatment of acute esophageal food impaction with glucagon, an effervescent agent, and water. Am J Roentgenol. 1994;162:325–328.

    Article  CAS  Google Scholar 

  7. American Society for Gastrointestinal Endoscopy. Guidelines: Management of ingested foreign bodies and food impactions. Gastrointest Endosc. 2011;73:1085–1091.

    Article  Google Scholar 

  8. Desai TK, Stecevic V, Chang CH, Goldstein NS, Badizadegan K, Furuta GT. Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc. 2005;61:795–801.

    Article  PubMed  Google Scholar 

  9. Sugawa C, Ono H, Taleb M, Lucas CE. Endoscopic management of foreign bodies in the upper gastrointestinal tract: A review. World J Gastrointest Endosc. 2014;6:475–481.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jason Haas.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Haas, J., Leo, J. & Vakil, N. Glucagon Is a Safe and Inexpensive Initial Strategy in Esophageal Food Bolus Impaction. Dig Dis Sci 61, 841–845 (2016). https://doi.org/10.1007/s10620-015-3934-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-015-3934-z

Keywords

Navigation